Literature DB >> 24135525

Progression of brain lesions in relation to hyperperfusion from subacute to chronic stages after experimental subarachnoid hemorrhage: a multiparametric MRI study.

Ivo A C W Tiebosch1, Walter M van den Bergh, Mark J R J Bouts, René Zwartbol, Annette van der Toorn, Rick M Dijkhuizen.   

Abstract

BACKGROUND: The pathogenesis of delayed cerebral injury after aneurysmal subarachnoid hemorrhage (SAH) is largely unresolved. In particular, the progression and interplay of tissue and perfusion changes, which can significantly affect the outcome, remain unclear. Only a few studies have assessed pathophysiological developments between subacute and chronic time points after SAH, which may be ideally studied with noninvasive methods in standardized animal models. Therefore, our objective was to characterize the pattern and correlation of brain perfusion and lesion status with serial multiparametric magnetic resonance imaging (MRI) from subacute to chronical after experimental SAH in rats.
METHODS: SAH was induced by endovascular puncture of the intracranial bifurcation of the right internal carotid artery in adult male Wistar rats (n = 30). Diffusion-, T2-, perfusion- and contrast-enhanced T1-weighted MRI were performed on a 4.7-tesla animal MR system to measure cytotoxic and vasogenic edema, hemodynamic parameters and blood-brain barrier permeability, respectively, at days 2 and 7 after SAH. The neurological status was repeatedly monitored with different behavioral tests between days -1 and 7 after SAH. Lesioned tissue - identified by edema-associated T2 prolongation - and unaffected tissue were outlined on multislice images and further characterized based on tissue and perfusion indices. Correlation analyses were performed to evaluate relationships between different MRI-based parameters and between MRI-based parameters and neurological scores.
RESULTS: Similar to clinical SAH and previous studies in this experimental SAH model, mortality up to day 2 was high (43%). In surviving animals, neurological function was significantly impaired subacutely, and tissue damage (characterized by T2 prolongation and diffusion reduction) and blood-brain barrier leakage (characterized by contrast agent extravasation) were apparent in ipsilateral cortical and subcortical tissue as well as in contralateral cortical tissue. Notably, ipsilateral cortical areas revealed increased cerebral blood flow and volume. Animals that subsequently died between days 2 and 7 after SAH had markedly elevated ipsilateral perfusion levels at day 2. After a week, neurological function had improved in surviving animals, and brain edema was partially resolved, while blood-brain barrier permeability and hyperperfusion persisted. The degree of brain damage correlated significantly with the level of perfusion elevation (r = 0.78 and 0.85 at days 2 and 7, respectively; p < 0.05). Furthermore, chronic (day 7 after SAH) blood-brain barrier permeability and vasogenic edema formation were associated with subacute (day 2 after SAH) hyperperfusion (r = 0.53 and 0.66, respectively; p < 0.05).
CONCLUSION: Our imaging findings indicate that SAH-induced brain injury at later stages is associated with progressive changes in tissue perfusion and that chronic hyperperfusion may contribute or point to delayed cerebral damage. Furthermore, multiparametric MRI may significantly aid in diagnosing the brain's status after SAH.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 24135525     DOI: 10.1159/000352048

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  8 in total

1.  Early CT perfusion changes and blood-brain barrier permeability after aneurysmal subarachnoid hemorrhage.

Authors:  Amanda Murphy; Airton Leonardo de Oliveira Manoel; Kyle Burgers; Ekaterina Kouzmina; Ting Lee; R Loch Macdonald; Aditya Bharatha
Journal:  Neuroradiology       Date:  2015-04-14       Impact factor: 2.804

2.  MRI Characterization in the Acute Phase of Experimental Subarachnoid Hemorrhage.

Authors:  Dewei Guo; D Andrew Wilkinson; B Gregory Thompson; Aditya S Pandey; Richard F Keep; Guohua Xi; Ya Hua
Journal:  Transl Stroke Res       Date:  2016-11-28       Impact factor: 6.829

3.  Blood-brain barrier permeability change and regulation mechanism after subarachnoid hemorrhage.

Authors:  Zhiqing Li; Guobiao Liang; Teng Ma; Jingchen Li; Ping Wang; Libo Liu; Bo Yu; Yunhui Liu; Yixue Xue
Journal:  Metab Brain Dis       Date:  2014-10-01       Impact factor: 3.584

4.  Multimodal MRI characterization of experimental subarachnoid hemorrhage.

Authors:  Y Sun; Q Shen; L T Watts; E R Muir; S Huang; G-Y Yang; J I Suarez; T Q Duong
Journal:  Neuroscience       Date:  2015-12-18       Impact factor: 3.590

5.  Spreading depolarizations increase delayed brain injury in a rat model of subarachnoid hemorrhage.

Authors:  Arend M Hamming; Marieke J H Wermer; S Umesh Rudrapatna; Christian Lanier; Hine J A van Os; Walter M van den Bergh; Michel D Ferrari; Annette van der Toorn; Arn M J M van den Maagdenberg; Ann M Stowe; Rick M Dijkhuizen
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-30       Impact factor: 6.200

Review 6.  A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage.

Authors:  Jenna L Leclerc; Joshua M Garcia; Matthew A Diller; Anne-Marie Carpenter; Pradip K Kamat; Brian L Hoh; Sylvain Doré
Journal:  Front Mol Neurosci       Date:  2018-03-22       Impact factor: 5.639

7.  Longitudinal, Quantitative, Multimodal MRI Evaluation of Patients With Intracerebral Hemorrhage Over the First Year.

Authors:  Muhammad E Haque; Seth B Boren; Octavio D Arevalo; Reshmi Gupta; Sarah George; Maria A Parekh; Xiurong Zhao; Jaraslow Aronowski; Sean I Savitz
Journal:  Front Neurol       Date:  2021-11-30       Impact factor: 4.003

8.  Acute T2*-Weighted Magnetic Resonance Imaging Detectable Cerebral Thrombosis in a Rat Model of Subarachnoid Hemorrhage.

Authors:  Jingwei Zhang; Kang Peng; Fenghui Ye; Sravanthi Koduri; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Transl Stroke Res       Date:  2021-06-02       Impact factor: 6.829

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.